EQS-News: ABVC BioPharma CEO Dr. Uttam Patil Recognized Among Elite Indian-Origin CEOs Making Global Impact in Science and Technology

ABVC BioPharma (NASDAQ: ABVC) closed a private placement of $3.39M in senior convertible notes, with proceeds used for working capital, subsidiary funding, and a $625K settlement. The notes mature in 2027 and are convertible into ABVC common stock. WallachBeth Capital acted as the placement agent.

ABVC BioPharma raised $3.39 million through discounted convertible notes, with proceeds for working capital, subsidiary funding, and a $625,000 settlement with Lind Global Fund II. The settlement resolves a financing dispute and related lawsuit, including warrant shares and a 12-month financing right for Lind.

ABVC BIOPHARMA, INC. (ABVC) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Item 1.01 Entry into a Material Definitive Agreement On August 21, 2026, ABVC BioPharma, Inc. (the “ Company ”) completed the previously announced partial legal and structural separation (the “ Reorganization Transactions ”) of its subsidiary, BioKey (Cayman), Inc., an exempted c

Sigma Lithium (NASDAQ: SGML) reported 3Q 26 preview, producing 7,293t of lithium oxide concentrate. It reduced short-term debt by 78% to US$28M and maintained 32% gross margins. Production resumed in 4Q 26 after a suspension, with 9,000t produced since restart. The company expects 240kt production over the next 12 months and 330kt in FY27. Cash position was US$10M as of September 30, 2026.

Stifel kept its Hold rating on Builders FirstSource but raised its price target to $58 from $55, suggesting a 10.6% downside from the last close. Recent analyst targets range from $56 to $75.

Netflix (NFLX) is cutting 2% to 3% of its London workforce, including regional production chief Anna Mallett, as part of a global restructuring. This follows a previous announcement to eliminate 1,000 roles worldwide. The moves aim to streamline operations amid Wall Street scrutiny over slowing growth and a 44% stock decline over the past year.